Literature DB >> 7603156

Cultural shift in Italy's drug policy.

S Garattini1.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7603156     DOI: 10.1016/s0140-6736(95)92647-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  The drug market in four European countries.

Authors:  S Garattini
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

2.  Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy.

Authors:  Margherita Andretta; Arcangelo Ciuna; Letizia Corbari; Andrea Cipriani; Corrado Barbui
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-01       Impact factor: 4.328

Review 3.  The last decade of Italian pharmaceutical policy: instability or consolidation?

Authors:  Giovanni Fattore; Claudio Jommi
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

4.  Prescription charges: change overdue? Britain can learn from systems of copayments based on drugs' effectiveness.

Authors:  T Walley
Journal:  BMJ       Date:  1998-08-22

5.  Discrepancy remains in pharmaceutical prescriptions in four European countries.

Authors:  S Garattini; L Garattini
Journal:  BMJ       Date:  1998-10-03

6.  The costs of pharmacological treatment for major depression. The Italian Prospective Multicentre Observational Incidence-Based Study.

Authors:  R Tarricone; G Fattore; S Gerzeli; G Serra; C Taddei; M Percudani
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.